⌘K

Login Start Free

Home/Filings/4/0001607062-16-000655

4//SEC Filing

GENEREX BIOTECHNOLOGY CORP 4

Accession 0001607062-16-000655

CIK 0001059784operating

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:10 PM ET

Size

15.2 KB

Accession

0001607062-16-000655

Insider Transaction Report

Form 4

Period: 2016-02-09

GENEREX BIOTECHNOLOGY CORPGNBT

Brusegard David

Chief Operating Officer

Transactions

Exercise/Conversion
Common Stock
2016-02-09$0.00/sh+5,583,775$5,584→ 3,916,104 total
Exercise/Conversion
Common Stock Purchase Option
2016-02-09−546,448→ 0 total
Exercise: $0.00From: 2012-06-20Exp: 2017-06-19→ Common Stock (546,448 underlying)
Exercise/Conversion
Common Stock Purchase Option
2016-02-09−1,928,925→ 0 total
Exercise: $0.00From: 2013-04-01Exp: 2018-04-01→ Common Stock (1,928,925 underlying)
Exercise/Conversion
Common Stock Purchase Option
2016-02-09−595,239→ 0 total
Exercise: $0.00From: 2013-06-06Exp: 2018-06-06→ Common Stock (595,239 underlying)
Exercise/Conversion
Common Stock Purchase Option
2016-02-09−845,492→ 0 total
Exercise: $0.00From: 2014-01-01Exp: 2018-10-31→ Common Stock (845,942 underlying)
Exercise/Conversion
Common Stock Purchase Option
2016-02-09+1,667,671→ 1,667,671 total
Exercise: $0.00From: 2016-02-09Exp: 2020-10-26→ Common Stock (1,667,671 underlying)

Documents

1 file

4
brusegard021216form4.xmlPrimary
FORM 4

Issuer

GENEREX BIOTECHNOLOGY CORP

CIK 0001059784

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001059784

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 4:10 PM ET
Size: 15.2 KB

View on SEC.gov